Home>Topics>Companies>Novo Nordisk

Novo Nordisk

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Novo Nordisk gets positive opinion on Tresiba for children in Europe

    Headlines

    Fri, 19 Dec 2014

    COPENHAGEN, Dec 19 (Reuters) - Drug maker Novo Nordisk said the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the use of its diabetes drug Tresiba for the treatment of children and adolescents.

  2. BRIEF-Per Aarsleff to build shell structure for Novo Nordisk

    Headlines

    Thu, 4 Dec 2014

    * Has entered into a partnering contract with Novo Nordisk A/S to build a shell structure with a total gross area of 15,000 square metres

  3. BRIEF- Novo Nordisk has reduced the number of executives to six

    Headlines

    Tue, 25 Nov 2014

    COPENHAGEN, Nov 25 (Reuters) - Novo Nordisk A/S : ** Has reduced the number of executives from seven to six ** Executive vice president and chief of staffs Lise Kingo has decided to leave Novo Nordisk

  4. Sanofi Shakes Off Patent Losses

    Headlines

    Mon, 24 Nov 2014

    However, we believe competition from Eli Lilly LLY and Novo Nordisk NVO in the next-generation basal insulin market will be ..... from upcoming competitive launches from Eli Lilly and Novo Nordisk . In late October, Sanofi's board of directors abruptly

  5. BRIEF- Novo'S victoza receives positive opinion for use in adults with type 2 diabetes

    Headlines

    Fri, 21 Nov 2014

    COPENHAGEN, Nov 21 (Reuters) - Novo Nordisk A/S : ** Victoza receives positive Committee for Medicinal Products for Human Use opinion opinion for use in adults with type

  6. Finding a Margin of Safety in a Fully Valued Market

    Headlines

    Fri, 21 Nov 2014

    contributing to its low uncertainty rating. However, new competition for Advate from the likes of Biogen Idec BIIB and Novo Nordisk NVO over the next few years could begin to erode the firm's dominant position in the U.S. market for hemophilia A

  7. Sanofi States Bullish Pipeline Outlook and Largely Flat Diabetes Guidance, Supporting Our Fair Value

    Commentary

    Thu, 20 Nov 2014

    next-generation basal insulins, including Sanofi's Toujeo. However, we believe competition from Eli Lilly and Novo Nordisk in the next-generation basal insulin market will be largely rational, which suggests stronger pricing power could

  8. 6 Key Concepts to Stock Investing Defined

    Headlines

    Thu, 6 Nov 2014

    duplicating a company’s products. For example, patents protect the excess returns of pharmaceutical manufacturers like Novo Nordisk NVO and Johnson & Johnson JNJ, and consumer products firms like Unilever UL and Coca-Cola KO can charge higher prices

  9. BRIEF-Nine out of 10 lost weight with Novo's obesity drug -study

    Headlines

    Tue, 4 Nov 2014

    Nov 4 (Reuters) - Novo Nordisk A/S says: * New phase 3a data demonstrate that nine out of 10 adults with obesity lost

  10. A Preview of the 2014 Morningstar International-Stock Fund Manager of the Year Competition

    Headlines

    Tue, 4 Nov 2014

    of strategies, have made lots of good picks in the health-care sector and the Indian market. Top-five holdings Novo Nordisk NVO and Novartis NVS have produced double-digit gains, for example, as have HDFC Bank HDB and Housing Development Finance

« Prev12345Next »
Content Partners